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Abstract: Cordyceps militaris (L.) Link, an edible entomopathogenic fungus widely used 
in traditional Chinese medicine, has numerous potential medicinal properties including 
antitumor activity. The methanolic extract of C. militaris fruiting body was recently shown to 
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have tumor cell growth inhibitory activity in several human tumor cell lines. Nonetheless, the 
mechanism of action involved is still not known. This work aimed at further studying the 
effect of the methanolic extract of C. militaris regarding its antitumor mechanism of action, 
using the non-small cell lung cancer cell line (NCI-H460) as a model. Results showed that 
treatment with the extract decreased cellular proliferation, induced cell cycle arrest at G0/G1 
and increased apoptosis. In addition, the extract increased the levels of p53 and p21. Moreover, 
an increase in p-H2A.X and 53BP1 levels, together with an increase in the number of 
53BP1 foci/cell (all indicative of DNA damage), were also observed after treatment with the 
extract. This work suggests that this extract affected NCI-H460 cellular viability through a 
mechanism involving DNA damage and p53 activation. This further supports the potential of 
this extract as a source of bioactive compounds, which may be used in anticancer strategies. 
Keywords: Cordyceps militaris methanolic extract; p53; p21; cell cycle arrest; DNA damage 
 
1. Introduction 
Cordyceps militaris (L.) Link, an edible Ascomycete, is an entomopathogenic fungus widely used 
in traditional Chinese medicine [1]. Indeed, it has been described as having numerous potent medicinal 
properties such as antitumor, anti-oxidant and anti-inflammatory [1,2]. 
Several studies, both in vitro as well as in human tumor xenografts in mice, refer to the antitumor 
activity of C. militaris [3,4]. The majority of these studies have been mainly carried out with water 
extracts [5–9] or with isolated compounds (namely cordycepin) [10,11]. 
On the other hand, information on the antitumor potential of methanolic extracts of C. militaris is 
still scarce, even though such activity has previously been described for the methanolic extracts of  
C. sinensis (a mushroom from the Cordyceps genus that is relatively similar to C. militaris, both at the 
biological as well at the chemical levels), in different tumor cell lines [1,12–14]. A previous study 
from some of us has shown that a methanolic extract of C. militaris fruiting body presented activity as 
inhibitor of cell growth towards a panel of human tumor cell lines (while not affecting the proliferation 
of non-tumor porcine liver primary cells). This effect was further confirmed in other human tumor  
cell lines, in a recently published work in which the composition and antitumor activity of methanolic 
extracts from the mycelia and fruiting body of C. militaris were compared [15]. However, to date, 
there is no information regarding the mechanism of action of this extract. 
Therefore, the present study aimed at understanding the mechanism of action of a methanolic 
extract of C. militaris, particularly its effect in cellular proliferation, cell cycle, apoptosis and DNA 
damage, using the NCI-H460 non-small cell lung cancer cell line as a model. 
2. Results and Discussion 
2.1. Effect of C. militaris Methanolic Extract in NCI-H460 Cell Viability 
We have previously shown that a methanolic extract from C. militaris fruiting body could inhibit cell 
growth in human tumor cell lines and was not toxic to non-tumor liver porcine primary cells (PLP2) [16]. 
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Decreased cell growth following treatment with this extract was recently further observed in various 
other human tumor cell lines [15]. Nevertheless, the mechanism of action of this extract has never been 
investigated. The present study aimed at gaining insight into the mechanism of action of the extract in 
a non-small cell lung cancer cell line (NCI-H460). The reason for selecting this cell line is that non-small 
cell lung cancer (NSCLC) is still a cause for many of the deaths related to cancer and, in addition, this cell 
line has wild-type p53 which would allow detecting p53 dependent mechanisms of action. 
The GI50 concentration of the methanolic extract of C. militaris had been previously found to be  
47.8 μg/mL for the NCI-H460 cells, using the sulforhodamine B (SRB) assay [16]. To further confirm 
this, the effect of the extract in NCI-H460 cells was analyzed in terms of cell viability, using the trypan 
blue exclusion assay. To observe a possible dose/response effect, two concentrations were selected,  
50 μg/mL (corresponding to the GI50 concentration) and 25 μg/mL (corresponding to half the GI50 
concentration). Results showed that the extract significantly decreased the NCI-H460 cell viability in  
a dose-dependent manner. Indeed, treatment with 25 μg/mL of extract reduced cell viability to  
42.3% ± 1.2% (in relation to blank cells) and treatment with 50 μg/mL further decreased cell viability 
to 28.0% ± 3.1% (Figure 1). 
 
Figure 1. Effect of C. militaris methanolic fruiting body extract on NCI-H460 cell viability. 
Viable cell number was analyzed 48 h after incubation with complete medium (Blank),  
25 μg/mL or 50 μg/mL extract or with the highest vehicle concentration (H2O). Results are 
presented as a percentage of viable cells in relation to blank cells and are the mean ± SEM 
of six independent experiments. ** p ≤ 0.001 blank vs. treatment. 
As expected, the vehicle (H2O) presented no effect on cell viability. From these results, we concluded 
that treatment with 50 μg/mL (GI50) caused a greater reduction of cell viability than expected (since  
the GI50 concentration reduces cell growth by 50%). The observed discrepancy between the GI50 
concentration determined with the SRB assay and the determination of viable cell number with that 
same concentration is not abnormal in these types of studies and may be justified by the differences in 
the methodologies used in both studies. Indeed, the SRB assay (which was carried out in the study by 
Reis et al. to determine the GI50 concentration [16]) was carried out in 5% FBS culture medium, whereas 
all the assays carried out in the present study were performed in 10% FBS supplemented medium. 
To assess the mechanisms involved in the decrease in cell viability induced by treatment with the 
extract, cell cycle profile and apoptosis were then analyzed. 
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2.2. Effect of the Extract on NCI-H460 Cellular Proliferation and Cycle Profile 
To understand if the extract was affecting proliferation of NCI-H460 cells, BrdU incorporation was 
analyzed after 48 h treatment of cells with the extract. Results revealed a significant and dose-dependent 
decrease in the levels of proliferation following treatment with the extract (Figure 2a). This was 
observed by a reduction in the percentage of BrdU-incorporating cells from 32.0% (Blank) to 18.7% 
following treatment with 25 μg/mL, which was further reduced to 4.1% following treatment with the 
50 μg/mL concentration. 
 
Figure 2. Effect of C. militaris methanolic fruiting body extract on NCI-H460 cellular 
proliferation (a); and cell cycle distribution (b). Cells were treated for 48 h with complete 
medium (Blank), 25 μg/mL or 50 μg/mL extract or with the highest vehicle (H2O) 
concentration. (a) Left panel: Representative fluorescence microscopy images of BrdU 
incorporation (green); and DAPI stained nuclei (blue). Bar corresponds to 20 μm. Right 
panel: % of BrdU-incorporating cells; (b) Left panel: Representative cell cycle histograms. 
Right panel: Distribution of cells in cell cycle phase. Results are the mean ± SEM of, at 
least, three independent experiments. * p ≤ 0.05 and ** p ≤ 0.001 blank vs. treatment. 
These results indicated that the extract might be affecting the normal cell cycle progression. Therefore, 
the cell cycle profile of NCI-H460 cells treated with the extract was analyzed by flow cytometry. This 
allows to easily estimate the percentage of cells in the different phases of the cell cycle [17]. Results 
showed clear alterations in the cell cycle profile of NCI-H460 cells following treatment with the extract, 
which were however only considered to be statistically significant with the highest concentration  
(50 μg/mL; Figure 2b). Indeed, treatment with this concentration of extract (50 μg/mL) caused an increase 
in the percentage of cells at the G0/G1 phase from 52.6% (Blank) to 71.7%. This was accompanied by 
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a decrease in percentage of cells in both the S and the G2/M phases. Indeed, a decrease in the S phase 
from 29.1% (Blank) to 17.1% (following treatment) was observed, as well as a decrease in the G2/M 
phase from 18.1% (Blank) to 7.0% (following treatment). 
Interestingly, a previous study using C. militaris and its mycelial fermentation has shown a similar 
effect in human glioblastoma cells, with both fractions arresting glioblastoma GBM8401 cells in the 
G0/G1 phase [18]. Nevertheless, in that same study, an arrest at the G2/M phase was also observed 
with the same extracts but in a different cell line (U-87MG cells). This suggests that the effect of the 
extract might depend on the genetic background of the tumor cells being treated [18]. Of interest in this 
context is another study in which cordycepin (an isolated compound from Cordyceps species, which 
seems to be present in the methanolic extract of C. militaris [15]) inhibited cell cycle progression of 
colorectal cancer cells at the G0/G1 phase [19]. We do not know which compounds are responsible for 
the cell cycle arrest in G0/G1 verified in the present study, but it is possible that cordycepin might be 
involved in such activity. Further studies aiming at confirming the presence of cordycepin in the studied 
extract and evaluating the effect of cordycepin in NCI-H460 cells, would allow further exploration of 
this possibility. 
2.3. Effect of the Extract on NCI-H460 Cellular Apoptosis 
The decrease in cellular viability that had been observed following treatment of NCI-H460 cells 
with the extract could also be due to increased cell death. Thus, the effect of the methanolic extract  
(25 and 50 µg/mL) on apoptosis was also investigated. Preliminary results showed a decrease in total 
PARP levels analyzed by Western blot (data not shown), which might indicate that PARP was being 
cleaved (considered a useful hallmark of apoptosis). To confirm the involvement of apoptosis in the 
mechanism of action of the extract, a specific apoptosis assay was used consisting in flow cytometric 
analysis of cells after labeling them with Annexin V-FITC/PI. Results showed that the extract induced 
apoptosis in cells treated with either of the concentrations being tested (Table 1). This was observed by a 
statistically significant increase in the levels of early apoptosis from 5.9% (in Blank cells) to 13.7% and 
21.4% (in NCI-H460 cells treated with 25 µg/mL or 50 µg/mL of the extract, respectively). 
Table 1. Apoptosis levels in NCI-H460 cells treated with C. militaris fruiting body 
methanolic extract. 
 
% Apoptosis 
Early Late 
Blank 5.9% ± 1.2% 1.5% ± 0.8% 
H2O 6.3% ± 2.0% 2.2% ± 0.5% 
C. militaris 
25 µg/mL 13.7% ± 1.4% * 3.4% ± 0.3% 
50 µg/mL 21.4% ± 4.2% * 5.0% ± 5.3% 
Results are the mean ± SEM of three independent experiments. * p ≤ 0.05 blank vs. treatment. 
Several studies have previously referred the apoptotic activity of other types of C. militaris extracts 
(namely aqueous extracts) in human tumor cell lines, including human leukemia cells [6,9], human 
breast cancer cells [8] and human lung carcinoma cells [20]. Interestingly, some of the C. militaris’ 
isolated compounds, namely cordycepin (described as being present in another methanolic extract of 
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C. militaris fruiting body [15]), have shown activity as apoptosis inducers in several human tumor  
cells [10,11,21]. 
2.4. Effect of the Extract in p53 and p21 Protein Levels in NCI-H460 Cells 
Given that the previous results showed that the methanolic extract caused cell cycle arrest (at G0/G1 
phase) and induced apoptosis in NCI-H460 cells, it was then decided to analyze the expression levels 
of p53 and p21 proteins in NCI-H460 cells following treatment with the extract. Results from the 
Western blot analysis clearly showed an increase in the expression of p53 protein following treatment 
with the extract. In addition, the levels of p21 (Figure 3) (a p53 transcriptional target [22] described as 
being a G1-checkpoint cyclin-dependent kinase inhibitor [23]), were also found to increase, supporting 
the idea that this extract exerts its function via p53. 
 
Figure 3. Expression of p53 and p21 in NCI-H460 cells following treatment with  
C. militaris methanolic fruiting body extract. Cells were treated for 48 h with complete 
medium (Blank), 25 μg/mL or 50 μg/mL of the extract or with the highest vehicle (H2O) 
concentration. Actin was used as a loading control. (a) Representative Western blot images 
of, at least, three independent experiments; (b) Densitometry analysis of the Western blots. 
Results are the mean ± SEM and are expressed after normalization of the values obtained for 
each protein with the values obtained for actin and further expressed in relation to treatment 
with 50 μg/mL extract. ** p < 0.01 blank vs. treatment. 
There has been increasing interest in finding strategies to increase p53’s activity in cancer therapy; 
p53 is considered the guardian of the genome and its activation is known to result in cell cycle delay  
(to allow DNA repair) and also to trigger cell death by apoptosis [24]. About 50% of all human cancers 
harbor mutations or loss of p53 expression [25,26], and even wild-type (wt) p53 cancers may also have 
downstream members of p53 regulatory signaling affected, which may lead to disruption in p53 
functions [27]. Therefore, strategies which result in p53 activation and of its targets could result in  
p53-dependent increase in cell death and cell cycle arrest, ultimately affecting tumor development in 
wt p53 tumors. 
2.5. Effect of the Extract in DNA Damage of NCI-H460 Cells 
Activation of p53 may result from DNA damage [22,28]. Therefore, to assess if the extract was 
causing DNA damage in NCI-H460 cells, the phosphorylation of H2A.X (a highly specific and sensitive 
molecular marker for DNA damage [29]) was analyzed in this study. Results showed an increase in the 
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levels of p-H2A.X following treatment with the extract (Figure 4a). Moreover, the levels of 53BP1 protein, 
an important mediator of the DNA damage response [30,31], were also found to increase after treatment 
with the extract (Figure 4b), together with an increase in its distribution at nuclear foci (Figure 4c), typical 
of cellular response to DNA damage [32]. Overall, these results suggest that the methanolic extract of 
C. militaris induces DNA damage. 
 
Figure 4. Effect of treatment with C. militaris methanolic fruiting body extract in NCI-H460 
cellular DNA damage. Cells were treated for 48 h with complete medium (Blank), 25 μg/mL 
or 50 μg/mL extract or with the highest vehicle (H2O) concentration. (a) Analysis of the 
expression of P-H2AX by Western blot. Actin was used as loading control. Left Panel: 
Representative images. Right Panel: Densitometry analysis of the Western blots. Results are 
expressed after normalization of the P-H2AX values with the values for actin and further 
expressed in relation to treatment with 50 μg/mL extract. Results are the mean ± SEM of, 
at least, three independent experiments (except for solvent control (H2O) which results from 
two experiments only); (b) Analysis of the expression of 53BP1 by Western blot. Actin 
was used as loading control. Left Panel: Representative images. Right Panel: Densitometry 
analysis of the Western blots. Results are expressed after normalization of the 53BP1values 
with the values for actin and further expressed in relation to blank. Results are the mean  
of two experiments only; (c) Analysis of the number of 53BP1 foci per cell. Left Panel: 
Representative fluorescence microscopy images of 53BP1 foci (green) and DAPI stained 
nuclei (blue). Bar corresponds to 20 μm. Right Panel: Quantification of 53BP1 foci. Results 
are the mean ± SEM of three independent experiments (except for the control (H2O), which 
results from two experiments only). * p ≤ 0.05 and ** p ≤ 0.01 blank vs. treatment. 
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In conclusion, our results showed that the methanolic extract of C. militaris at the 25 μg/mL 
concentration significantly inhibited cell proliferation and induced apoptosis of NCI-H460 cells. However, 
this concentration did not significantly inhibited p53 and p21 expression and DNA damage (even though 
statistically significant increases in the concentrations of these proteins were verified with 50 μg/mL). 
These results suggest that C. militaris may have other intracellular mechanisms leading to apoptosis of 
NCI-H460 cells. This will be investigated in future work. 
3. Experimental Section 
3.1. Extract 
The methanolic extract used in this study was obtained from cultivated fruiting bodies of  
Cordyceps militaris (L.) Link (strain: MCI 10304, Meshtech Cordyceps Institute, Bangkok, Thailand), 
as published in [16]. The chemical characterization of the studied extract is provided in the same 
publication. Briefly, lyophilized sample was extracted by stirring with methanol for 1 h and filtered 
through Whatman No. 4 paper. The residue was then extracted with methanol for 1 h. The combined 
methanolic extracts were evaporated at 40 °C to dryness. A stock solution at 8 mg/mL in H2O was kept 
at −20 °C. 
3.2. Cell Culture 
The non-small cell lung cancer cell line NCI-H460 (a kind gift from NCI, Bethesda, MD, USA) was 
maintained in RPMI-1640 medium with UltraGlutamine I and 25 mM Hepes (Lonza, Basel, Switzerland) 
supplemented with 10% FBS (Biowest, Nuaillé, France) at 37 °C in a humidified incubator with 5% 
CO2 in air. Cell number and viability were assessed with Trypan blue exclusion assay. All experiments 
were carried out with exponentially growing cells (presenting more than 90% cell viability). 
3.3. Cell Treatments with C. militaris Extract 
Cells (1 × 105 cells/well) were plated in 6-well plates and incubated for 24 h at 37 °C in 5% CO2 to 
allow cell adhesion. Cells were then treated for 48 h with 25 μg/mL or 50 μg/mL of the extract for  
48 h. Cells were also treated with complete medium (Blank) or with the corresponding concentrations 
of the extract solvent (H2O, Control). Following treatment, cells were processed according to different 
protocols, as follows. 
3.3.1. Analysis of Cell Cycle Profile by Flow Cytometry 
Following 48 h treatment, cell pellets were fixed in ice-cold 70% ethanol for at least 12 h. Cells 
were then resuspended in 5 μg/mL propidium iodide and 0.1 mg/mL RNase A in PBS. Cellular DNA 
content was analyzed using a FACSCalibur flow cytometer (BD Biosciences). The percentage of cells 
in the different phases of cell cycle (G0/G1, S and G2/M) was determined by plotting at least 20,000 
events per sample, after excluding cell debris and aggregates [33], using the FlowJo 7.6.5 software 
(Tree Star, Inc., Ashland, OR, USA). 
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3.3.2. Analysis of Cellular Proliferation with the BrdU Incorporation Assay 
Following 47 h treatment, cells were incubated for 1 h with 10 μM 5-bromo-2′-deoxyuridine (BrdU, 
Sigma-Aldrich) at 37 °C and 5% CO2. Cells were then washed, fixed in 4% paraformaldehyde and 
cytospins prepared. Following a DNA denaturation step consisting of 20 min incubation in 2 M HCl at 
room temperature, cells were incubated with mouse anti-BrdU antibody (1:10; Dako) for 1 h at room 
temperature and further incubated in the dark with anti-mouse-Ig-FITC (1:100; Dako, Glostrup, 
Denmark) for 30 min. Cells were then washed again twice with PBS-T-B and slides were prepared with 
Vectashield mounting medium with DAPI (Vector Laboratories Inc, Burlingame, CA, USA). BrdU 
incorporation was analyzed using a fluorescence microscope (Leica DM2000) and the percentage of 
BrdU incorporating cells determined by a counting at least 500 cells for each condition [34]. 
3.3.3. Analysis of Apoptosis by Flow Cytometry 
Following 48 h treatment, analysis of apoptotic cell death was carried out using the “Annexin  
V-FITC Apoptosis Detection kit” (Bender MedSystems, Vienna, Austria) as previously described [35]. 
Cells were analyzed by flow cytometry in a FACSCalibur flow cytometer (BD Biosciences, San Jose, 
CA, USA). All data was analyzed using the FlowJo 7.6.5 software (Tree Star, Inc., Ashland, OR, USA), 
plotting at least 20,000 events per sample. 
3.3.4. Analysis of Protein Expression by Western Blot 
Following 48 h treatment with the extract, total protein lysates were prepared by lysing cell pellets 
in Winman’s Buffer (1% NP-40, 0.1 M Tris-HCl pH 8.0, 0.15 M NaCl and 5 mM EDTA). Total 
protein content was quantified using the “DC Protein assay kit” (Bio-Rad) and protein (30 µg) was 
subjected to SDS-PAGE (12% Bis-Tris gel). Following electrophoretic transfer onto nitrocellulose 
membranes (GE Healthcare), membranes were incubated with the following primary antibodies: 
Mouse anti-p53 (1:200; Thermo-Scientific, Waltham, MA, USA), mouse anti-p21 (1:250; Calbiochem, 
San Diego, CA, USA), mouse anti-53BP1 (1:400; Santa Cruz Biotechnology), p-Histone H2A.X  
(Ser 139) (1:200; Santa Cruz Biotechnology Inc, Heidelberg, Germany) and goat anti-Actin (1:2000; 
Santa Cruz Biotechnology). The following secondary antibodies were then used: Anti-mouse IgG-HRP; 
anti-rabbit IgG-HRP or anti-goat IgG-HRP (all diluted 1: 2000, Santa Cruz Biotechnology). Signal was 
detected with the ECL Western blot Detection kit (GE Healthcare, Buckinghamshire, UK), Hyperfilm 
ECL (GE Healthcare) and the Kodak GBX developer and fixer (Sigma) [36,37]. The intensity of the bands 
obtained in each film was quantified using the Quantity One software (BioRad, Hercules, CA, USA). 
3.3.5. Analysis of 53BP1 Expression by Immunofluorescence 
Following 48 h treatment with the extract, cells were fixed in 4% paraformaldehyde and cytospins 
were prepared. Cells were incubated for 10 min in 50 mM NH4Cl in PBS and permeabilized in  
ice-cold 0.2% Triton X-100 in PBS for 10 min. After a blocking step with 2% BSA in PBS for 20 min, 
cells were incubated with rabbit 53BP1 antibody (Santa Cruz Biotechnology) diluted 1:200 in 2% BSA 
in PBS, overnight at 4 °C. Cells were then washed with 2% BSA in PBS and further incubated with  
rabbit-IgG-FITC antibody (1:100; Dako) for 1 h, at room temperature. Slides were mounted in 
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Vectashield Mounting Media with DAPI (Vector Laboratories Inc, Burlingame, CA, USA) and cell 
images were taken using a fluorescence microscope ZEISS Axio Imager.Z1 coupled with ApoTome 
Imaging System microscope. Exported images in TIFF format were decompressed with Irfanview  
(ver. 4.35, Irfan Skiljan, Vienna, Austria) and analyzed with ImageJ software (version 1.46r). This was 
carried out using a program written by Dr. Niklas Schultz (GMT Department, Stockholm University, 
Sweden [38]) which analyses DAPI and FITC channels independently, detects cell nuclei and registers 
foci parameters within the nuclear area. Different parameters such as foci area, intensity and the 
number of foci per nucleus were given in the output file [39]. 
3.4. Statistical Analysis 
All presented data results were obtained from at least three independent experiments (unless otherwise 
stated in the results section). All data was statistically analyzed with the two-tailed paired Student’s  
t-test (except for the data presented in Figure 2b and in Table 1, which were analyzed with the unpaired 
Student’s t-test). Results were considered statistically significant when p ≤ 0.05. 
4. Conclusions 
This study showed that a methanolic extract of Cordyceps militaris fruiting body reduced the number 
of viable NCI-H460 human tumor cells by decreasing cellular proliferation, increasing the number of 
cells in the G0/G1 phase of the cell cycle and inducing cell death by apoptosis. Moreover, this extract 
was shown to probably induce DNA damage and to increase the cellular levels of p53 and p21. This is 
particularly interesting since p53 is an attractive therapeutic target and molecules causing an increase 
in p53 wt levels may contribute to the development of anticancer therapies. However, in order to 
further confirm the mechanism of action of this extract further studies would be required, namely 
studies on the effect of this extract on NCI-H460 cells following p53 silencing and on other tumor cell 
lines without p53 or with a p53 mutation. Furthermore, additional studies on the effect of compounds 
isolated from this extract would also be important. Indeed, the chemical characterization of this extract 
has already allowed the identification of p-hydroxybenzoic and cinnamic acids [16]. In addition, 
cordycepin (an isolated compound from Cordyceps species) seems to be present in methanolic extract 
of C. militaris [15]. The effect of all these compounds has been previously studied in NCI-H460 cells, 
with both cordycepin and cinnamic acid showing in vitro cell growth inhibitory activity [40,41]. 
Nevertheless, when addressing the possibility of using extracts/isolated compounds in vivo, extrapolation 
of the results obtained using cell line models must be carefully analyzed. Pharmacokinetic studies, as well 
as the optimization of treatment conditions, are needed in order to be successful. Overall, this work 
further supports the potential of C. militaris extracts in the search for bioactive compounds, which may 
be of use in anticancer strategies. 
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